लोड हो रहा है...

Treatment of Bone Fragility in Patients with Diabetes: Antiresorptive versus Anabolic?

PURPOSE OF REVIEW: The pathogenesis of bone fragility in diabetes has not been fully characterized. The anti-fracture efficacy of available therapies remains unproven in patients with diabetes. We aim to collate current evidence of the treatment of diabetic bone fragility, and to provide a rationale...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Curr Opin Endocrinol Diabetes Obes
मुख्य लेखकों: Shah, Meghna, Appuswamy, Anusha Veeravanallur, Rao, Sudhaker D., Dhaliwal, Ruban
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244995/
https://ncbi.nlm.nih.gov/pubmed/34010225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000645
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!